Detection of recurrent colon cancer with In-111 labeled MoAb B72.3 in a patient with normal CEA and TAG-72 levels

V. Vijayakumar, M. J. Blend, D. Johnson, K. Schnobrich, J. Golick

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The usefulness of radioimmunoscintigraphy with In-111 labeled MoAb B72.3 is illustrated in this case report of a patient with an aggressive cancer of the ascending colon. When used in conjunction with CT, ultrasound examination, and MRI, radioimmunoscintigraphy improved the specificity of these other imaging modalities, although the patient's serum CEA and TAG-72 levels remained within the normal ranges. In addition, MoAb imaging demonstrated superiority over CT in identifying an additional unsuspected lesion. Detection of occult disease by imaging modalities with or without elevated serum CEA levels is discussed.

Original languageEnglish (US)
Pages (from-to)180-184
Number of pages5
JournalClinical Nuclear Medicine
Volume17
Issue number3
StatePublished - 1992

Fingerprint

Radioimmunodetection
Colonic Neoplasms
Ascending Colon
Serum
Reference Values
tumor-associated antigen 72
B72.3 antibody

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Detection of recurrent colon cancer with In-111 labeled MoAb B72.3 in a patient with normal CEA and TAG-72 levels. / Vijayakumar, V.; Blend, M. J.; Johnson, D.; Schnobrich, K.; Golick, J.

In: Clinical Nuclear Medicine, Vol. 17, No. 3, 1992, p. 180-184.

Research output: Contribution to journalArticle

Vijayakumar, V. ; Blend, M. J. ; Johnson, D. ; Schnobrich, K. ; Golick, J. / Detection of recurrent colon cancer with In-111 labeled MoAb B72.3 in a patient with normal CEA and TAG-72 levels. In: Clinical Nuclear Medicine. 1992 ; Vol. 17, No. 3. pp. 180-184.
@article{4d363fbdddcf4678bf7ba135ab4499ac,
title = "Detection of recurrent colon cancer with In-111 labeled MoAb B72.3 in a patient with normal CEA and TAG-72 levels",
abstract = "The usefulness of radioimmunoscintigraphy with In-111 labeled MoAb B72.3 is illustrated in this case report of a patient with an aggressive cancer of the ascending colon. When used in conjunction with CT, ultrasound examination, and MRI, radioimmunoscintigraphy improved the specificity of these other imaging modalities, although the patient's serum CEA and TAG-72 levels remained within the normal ranges. In addition, MoAb imaging demonstrated superiority over CT in identifying an additional unsuspected lesion. Detection of occult disease by imaging modalities with or without elevated serum CEA levels is discussed.",
author = "V. Vijayakumar and Blend, {M. J.} and D. Johnson and K. Schnobrich and J. Golick",
year = "1992",
language = "English (US)",
volume = "17",
pages = "180--184",
journal = "Clinical Nuclear Medicine",
issn = "0363-9762",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Detection of recurrent colon cancer with In-111 labeled MoAb B72.3 in a patient with normal CEA and TAG-72 levels

AU - Vijayakumar, V.

AU - Blend, M. J.

AU - Johnson, D.

AU - Schnobrich, K.

AU - Golick, J.

PY - 1992

Y1 - 1992

N2 - The usefulness of radioimmunoscintigraphy with In-111 labeled MoAb B72.3 is illustrated in this case report of a patient with an aggressive cancer of the ascending colon. When used in conjunction with CT, ultrasound examination, and MRI, radioimmunoscintigraphy improved the specificity of these other imaging modalities, although the patient's serum CEA and TAG-72 levels remained within the normal ranges. In addition, MoAb imaging demonstrated superiority over CT in identifying an additional unsuspected lesion. Detection of occult disease by imaging modalities with or without elevated serum CEA levels is discussed.

AB - The usefulness of radioimmunoscintigraphy with In-111 labeled MoAb B72.3 is illustrated in this case report of a patient with an aggressive cancer of the ascending colon. When used in conjunction with CT, ultrasound examination, and MRI, radioimmunoscintigraphy improved the specificity of these other imaging modalities, although the patient's serum CEA and TAG-72 levels remained within the normal ranges. In addition, MoAb imaging demonstrated superiority over CT in identifying an additional unsuspected lesion. Detection of occult disease by imaging modalities with or without elevated serum CEA levels is discussed.

UR - http://www.scopus.com/inward/record.url?scp=0026752767&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026752767&partnerID=8YFLogxK

M3 - Article

C2 - 1611787

AN - SCOPUS:0026752767

VL - 17

SP - 180

EP - 184

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

SN - 0363-9762

IS - 3

ER -